Spotlight on Alzheimer's disease and related dementias research in East Asia
Authors:
Open Access
- 10 July 2025
- journal article
- editorial
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (7) , e70479
Abstract
With a burgeoning dementia burden driven by unique demographic, genetic, and socioeconomic factors of East Asia, the region has made significant investments in understanding disease mechanisms, developing biomarkers, and exploring therapeutic approaches. This collection highlights the current landscape of Alzheimer's disease and related dementias research in East Asia, including region‐specific epidemiological insights, advances in plasma biomarkers and neuroimaging, and innovative diagnostic and treatment strategies. Despite progress, challenges such as limited access to advanced imaging, cultural barriers to autopsy, and disparities in healthcare persist.Keywords
This publication has 41 references indexed in Scilit:
- Tau pathology is associated with synaptic density and longitudinal synaptic loss in Alzheimer’s diseaseMolecular Psychiatry, 2024
- APOE ε4 is associated with decreased synaptic density in cognitively impaired participantsAlzheimer's & Dementia, 2024
- Associations between cardiometabolic multimorbidity and cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact adults: the CABLE studyAlzheimer's Research & Therapy, 2024
- Metabotropic glutamate receptor 5 (mGluR5) is associated with neurodegeneration and amyloid deposition in Alzheimer’s disease: A [18F]PSS232 PET/MRI studyAlzheimer's Research & Therapy, 2024
- Chinese Preclinical Alzheimer's Disease Study (C-PAS): Design and Challenge from PET AcceptanceThe Journal Of Prevention of Alzheimer's Disease, 2023
- GSNgene frameshift mutations in Alzheimer’s diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2023
- A combination model of AD biomarkers revealed by machine learning precisely predicts Alzheimer's dementia: China Aging and Neurodegenerative Initiative (CANDI) studyAlzheimer's & Dementia, 2022
- Dynamic changes of CSF sPDGFRβ during ageing and AD progression and associations with CSF ATN biomarkersMolecular Neurodegeneration, 2022
- Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional studyThe Lancet Public Health, 2020
- Japanese and North American Alzheimer's Disease Neuroimaging Initiative studies: Harmonization for international trialsAlzheimer's & Dementia, 2018